PubHawk
December 2021 PMID 34449181

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.

Bertram Pitt, Gerasimos Filippatos, Rajiv Agarwal, Stefan D Anker, George L Bakris, Peter Rossing, Amer Joseph, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Luis M Ruilope

Full text PDF Download social card

Mentions

385
Peak: 84 in Aug 2021
across 6 sources since Aug 2021

Extended reach

1,273,346
potential audience

Total likes

380

Video views

617

Mentions per month

Aug 2021 – Aug 2025

Where it's discussed

  • X / Twitter304 posts
  • News62 articles
  • Facebook8 posts
  • Blogs6 articles
  • YouTube4 videos
  • Bluesky1 posts

AI synopsis

What people are saying

The discussions overwhelmingly support the study's positive outcomes, with phrases like 'practice-changing trial' and references to improved cardiovascular outcomes, indicating strong agreement and perceived high impact. The tone is professional and technical, with many examples citing specific trial names like FIDELIO, FIGARO, and detailed statistics, which demonstrate a high level of interest and engagement in advancing treatment strategies.

AgreementStrong agreement

Most discussions express strong support and highlight the positive results of the finerenone trials, emphasizing its effectiveness and potential as a practice-changing treatment.

InterestHigh interest

The posts show high academic and professional interest, referencing detailed trial outcomes, primary endpoints, and clinical implications.

EngagementModerate engagement

While many posts delve into clinical details and implications, some are reposts or summaries, indicating moderate engagement with some variation in depth.

ImpactHigh impact

The overall tone reflects the belief that these findings significantly influence current treatment approaches for CKD and T2D, suggesting a high impact in nephrology and cardiology fields.

Abstract in brief

  • The study investigated the effects of finerenone, a medication that blocks mineralocorticoid receptors, on cardiovascular and kidney outcomes in patients with type 2 diabetes and different stages of chronic kidney disease (CKD).
  • Patients were randomly given either finerenone or a placebo, and the main focus was on preventing serious cardiovascular events such as heart attacks, strokes, or heart failure hospitalizations, with secondary outcomes including kidney failure and significant decline in kidney function.
  • Results showed that finerenone significantly reduced the risk of major cardiovascular events compared to placebo, mainly by lowering hospitalizations related to heart failure, suggesting it may be beneficial for a broader range of CKD patients with type 2 diabetes.
Read the full abstract

Top posts

Most liked on X and Bluesky
Diego Segura-Rodríguez
@SeguraCardio · X

Aug 28, 2021 · 63 likes · 19 shares · 25,725 followers View post →
Nephrology Journal Club
@NephJC · X

Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patients with HF, DM, and CKD? #NephJC https://t.co/xQq6AKyHGA https://t.co/qVaEOBvWGp

Oct 9, 2024 · 51 likes · 15 shares · 38,232 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co/T6Tq2388a1 FIGARO-DKD https://t.co/r1V46C0aSU FIDELITY https://t.co/PgJJR8kI8B #VisualAbstract by @whatsthegfr #ISNWCN

Feb 26, 2022 · 32 likes · 18 shares · 33,509 followers View post →
José R. Juanatey
@JoseJuanatey · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejorar el pronóstico de diabéticos con enfermedad renal crónica! ⁦@secardiologia⁩ #ESCcongress https://t.co/mJK0PygMiF

Aug 28, 2021 · 21 likes · 11 shares · 13,758 followers View post →
Dr Amar Puttanna
@AmarPut · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @drpatrickholmes @drkevinfernando @kamleshkhunti @cardiomet_CE @GoggleDocs @brendonneuen @VladoPerkovic @SABOURETCardio @hvanspall @ErinMichos @docwas

Aug 28, 2021 · 20 likes · 9 shares · 3,623 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD with elevated albuminuria or stage 1 or 2 CKD with severely elevated albuminuria, finerenone therapy improved cardiovascular outcomes https://t.co/qOGe2abT4i https://t.co/jczBKaaqSO

Mar 1, 2025 · 19 likes · 11 shares · 2,639 followers View post →

All mentions

Marco Anaya_NefroX
@Nefrotweet · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Aug 26, 2025 · 178 shares · 1,742 followers View post →
Mohamed E. Elrggal
@M_Elraggal · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Aug 26, 2025 · 178 shares · 1,698 followers View post →
Ahmed Serageldeen
@ahmed_shaban_s · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Aug 26, 2025 · 178 shares · 224 followers View post →
Roberto Gutiérrez
@DrRobertoGuti · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 9, 2025 · 178 shares · 782 followers View post →
NephroLOGY BOX. GUO's
@ulusalokyay · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 9, 2025 · 178 shares · 169 followers View post →
diacavan
@diacavan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 165 followers View post →
Karo Vivanco✌
@Karovivanco29 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 933 followers View post →
Magaly Abarca Pineda
@Magalyabarca · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 248 followers View post →
Vademon24292
@CarlosA09557330 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 519 followers View post →
Erik on the Run
@Erik_RB16b · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 332 followers View post →
Franklin Loachamin
@FranLoachamin · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 4,883 followers View post →
Nep
@HadiMD_ · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 351 followers View post →
Milagros Flores
@dra_miliflores · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 908 followers View post →
nyiminhan
@nyiminhan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 7, 2025 · 178 shares · 543 followers View post →
د علي السهو FRCPC, FASN, FISN
@alialsahow · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 7, 2025 · 178 shares · 2,065 followers View post →
Manuel Gaxiola
@cardiogax · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 6, 2025 · 178 shares · 7,977 followers View post →
Mohammad Aleidi
@aleidimed · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 6, 2025 · 178 shares · 270 followers View post →
marc0
@markosycc · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 6, 2025 · 178 shares · 20 followers View post →
Edson Makambwa
@EdsonMakambwa · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 6, 2025 · 178 shares · 41 followers View post →
KittyKat555
@KatieSh74387435 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 29, 2025 · 178 shares · 925 followers View post →
TISOYMD
@TisoyMDSays · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 23, 2025 · 178 shares · 694 followers View post →
Johanna Calib Macataman
@itsjohannacm · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 21, 2025 · 178 shares · 23 followers View post →
Nefrología UMAE 71
@NefroUmae71 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 17, 2025 · 178 shares · 190 followers View post →
Sayed S. Rahman
@SayedSRahman1 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 16, 2025 · 178 shares · 151 followers View post →
Sophia Crawford
@Crawford2Sophia · X

RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…

Mar 10, 2025 · 11 shares · 119 followers View post →
Nikhil Bassi, MD
@NikhilBassiMD · X

RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…

Mar 9, 2025 · 11 shares · 641 followers View post →
Jez Chua
@jezchuamd · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 6, 2025 · 178 shares · 11 followers View post →
Pedro Betancourt
@Pedrob251 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 5, 2025 · 178 shares · 1,829 followers View post →
Clinical cardiology
@Mahmoud33986639 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 4, 2025 · 178 shares · 240 followers View post →
Dr. Ambily K
@drambilyk · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 3, 2025 · 178 shares · 311 followers View post →
Irving Trejo Curiel
@irvtc · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 3, 2025 · 178 shares · 33 followers View post →
Koushik Chakma
@Koushikchak2013 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 3, 2025 · 178 shares · 8 followers View post →
Bhavya dasara
@bhavya_dasara · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 788 followers View post →
MariGeli
@yo32185 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 34 followers View post →
MariGeli
@GeliYo32185 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 31 followers View post →
José Luiz
@nefrotweets · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 96 followers View post →
Nefrología HRLALM
@NefroHRLALM · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 210 followers View post →
Ale Padron
@nefroalejapatch · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 50 followers View post →
EmmaHuang
@EmmaHuang81 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 92 followers View post →
Dr.Trauma_Do
@Dr_Trauma_do · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 43 followers View post →
Alina Martin
@alinamartin811 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 8 followers View post →
Natsir Ramadhan
@natsiradhan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 557 followers View post →
Ibn Aris
@ibenzimidazole · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 947 followers View post →
Nefrologo Roman Hernandez Rios
@NefroRomanHdez · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 443 followers View post →
Alexandro Franco Estrada
@AlexEstradaF · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 104 followers View post →
Dr. No
@DRCRITICALCARE3 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 477 followers View post →
Goaty 2 am
@OGoaty5 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 494 followers View post →
Sara Almutar
@s_almutar · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 1,552 followers View post →
Dr. Carlos Orellana
@orellanamd · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 553 followers View post →
diacavan
@diacavan · X

RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…

Mar 1, 2025 · 11 shares · 165 followers View post →
さく
@za_yi · X

RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…

Mar 1, 2025 · 11 shares · 883 followers View post →
Ppp
@Pingg_niP · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 399 followers View post →
Laura Pérez
@tatana2007 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 237 followers View post →
Laura Pérez
@tatana2007 · X

RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…

Mar 1, 2025 · 11 shares · 237 followers View post →
Carmela Ramos
@carmelanefro · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 6 followers View post →
Oscar
@OscarAlfredoLu4 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 192 followers View post →
Miguel Turégano
@tureyedro · X

RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…

Mar 1, 2025 · 11 shares · 813 followers View post →
M. Azman Pasha
@PandAzman · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 617 followers View post →
Juan Santiago
@JohnLMJ · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 367 followers View post →
Sam
@spanday31 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 277 followers View post →
diacavan
@diacavan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 165 followers View post →
Julio César
@DrJulioMatuteM · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 1,427 followers View post →
Marcello Di Zenzo
@ZenzoMarcello · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 72 followers View post →
Aarthi Muthukumaran
@aarthi_dr · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 1,543 followers View post →
Luis Ribeiro
@ribeiro_queiros · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 144 followers View post →
Vincci Monique Salud, M.D.
@moniquecularMD · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 84 followers View post →
Takuya Kishi @ねこ好き循環器内科医
@tkishi_cardiol · X

RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…

Mar 1, 2025 · 11 shares · 14,660 followers View post →
M Azfar Qureshi
@MAQ_Renal · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 165 followers View post →
R A Popalzai
@Radion_Popalzai · X

RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…

Mar 1, 2025 · 11 shares · 4,615 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD with elevated albuminuria or stage 1 or 2 CKD with severely elevated albuminuria, finerenone therapy improved cardiovascular outcomes https://t.co/qOGe2abT4i https://t.co/jczBKaaqSO

Mar 1, 2025 · 19 likes · 11 shares · 2,639 followers View post →
Estefanía Argüello
@tefitasaloata · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 15 followers View post →
Namesh kamat
@namesh217 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 244 followers View post →
MedEd Global Solutions
@global_meded · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 244 followers View post →
Victor Hernández
@VicHdez27 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 140 followers View post →
Mike Tenckhoff
@miguel_mgtz7 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 515 followers View post →
Manika Adari
@ManikaAdari · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 20 followers View post →
GHAZALI, M.D
@MGhazali225 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 158 followers View post →
Emmanuel Bailon
@2807Mababa · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 17 followers View post →
Caps, MD
@Caaaapslock_ · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 599 followers View post →
Diana Zambri
@dianitazambri · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 169 followers View post →
Abc
@abraham_0699 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 20 followers View post →
Mayra Avilés
@marsdance21 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 296 followers View post →
S.Runprapan
@wwanderlusterr · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 48 followers View post →
Cristhian Muñoz
@CristhianMuM · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 951 followers View post →
Armando Morales S.
@amsnefrologo · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 15 followers View post →
Cardiogrumpy
@Khabelo · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 264 followers View post →
Spandana Ravada Vora
@spandanaravada · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 178 followers View post →
Dr Theepa N.M.R
@TNesam · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 697 followers View post →
Joyce Bwombengi
@kemuntoMD · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 1,080 followers View post →
そらまめ医
@YiSoramame · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 439 followers View post →
refntokyo
@tokyo_Oli_drift · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 274 followers View post →
Brian Ricardo Garibay Vega
@BrianGaribayV · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 101 followers View post →
Pawan Rao MD, FASN
@nephronus · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 994 followers View post →
Prawesh Adhikari
@PraweshAdhikar1 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 25 followers View post →
CLEO
@CleoKrg · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 40 followers View post →
Alsun Cabarles
@HarriZoon · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 126 followers View post →
EOLO MORANDI JR.
@eolojr · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 539 followers View post →
rubensg.
@un_rubens · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 224 followers View post →
Aurora Beatriz Tutiven Ubilla
@AuroraTutiven · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 199 followers View post →
Nader
@Nader62321135 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 86 followers View post →
Nefrología CMN SXXI
@NefroCMNSXXI · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 1,178 followers View post →
Ken Lim, MD PhD
@TheLimLab · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 278 followers View post →
Elías
@ElasV05 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 102 followers View post →
Umut Kocabaş
@UmutKocabasMD · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 1,459 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 9,131 followers View post →
Dr NAGA SHASHIKANTH P
@NagaShashikanth · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 74 followers View post →
Almansour
@malmansour81 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 207 followers View post →
Clemente Porras
@Memeporras · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 79 followers View post →
Lamri Aldjia
@AldjiaLamri · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 141 followers View post →
Edgar V. Lerma
@edgarvlermamd.bsky.social · Bluesky

Finerenone trials #PSHPLAS

Feb 28, 2025 · 11 likes · 5 shares View post →
Misato Chimura
@chim97834 · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 11, 2024 · 15 shares · 36 followers View post →
Laura Pérez
@tatana2007 · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 11, 2024 · 15 shares · 237 followers View post →
Juan Pablo Flores
@JuanPablo_Fs · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 11, 2024 · 15 shares · 104 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 11, 2024 · 15 shares · 9,131 followers View post →
Juan Carlos Obaya
@jcobaya69 · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 11, 2024 · 15 shares · 857 followers View post →
Doc Dorin
@doriny27 · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 11, 2024 · 15 shares · 976 followers View post →
H. A. A.
@tondercath · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 10, 2024 · 15 shares · 229 followers View post →
Dr. Carlos Orellana
@orellanamd · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 10, 2024 · 15 shares · 553 followers View post →
Ana Oliva
@AnaOliva31 · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 10, 2024 · 15 shares · 86 followers View post →
Leo Vin
@nefro40 · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 10, 2024 · 15 shares · 1,297 followers View post →
Carmela Ramos
@Carmen98607067 · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 10, 2024 · 15 shares · 4 followers View post →
Sarah Melville
@sarahkmels · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 10, 2024 · 15 shares · 2,174 followers View post →
Cristina Popa
@NephroSeeker · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 9, 2024 · 15 shares · 2,965 followers View post →
Elba Medina
@elbaonelida · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 9, 2024 · 15 shares · 1,049 followers View post →
د.خديجة خويلد
@PNdfwf0e0TPPBY6 · X

RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…

Oct 9, 2024 · 15 shares · 466 followers View post →
Nephrology Journal Club
@NephJC · X

Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patients with HF, DM, and CKD? #NephJC https://t.co/xQq6AKyHGA https://t.co/qVaEOBvWGp

Oct 9, 2024 · 51 likes · 15 shares · 38,232 followers View post →
Swapnil Hiremath @hswapnil.medsky.social
@hswapnil · X

RT @NephJC: After FIDELIO, Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone fo…

Oct 8, 2024 · 2 shares · 21,697 followers View post →
Nephrology Journal Club
@NephJC · X

After FIDELIO, Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patients with HF, DM, and CKD? #NephJC https://t.co/xQq6AKy9R2

Oct 8, 2024 · 14 likes · 2 shares · 38,232 followers View post →
Joyce Bwombengi
@kemuntoMD · X

RT @cardiomet_CE: 35) In the #SGLT2i and #MRAtrials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:

Jun 10, 2024 · 3 shares · 1,080 followers View post →
Jose De La Flor
@josedelaflor4 · X

RT @NephJC: Evidence on efficacy

May 23, 2024 · 1 share · 456 followers View post →
Nephrology Journal Club
@NephJC · X

Evidence on efficacy

May 22, 2024 · 5 likes · 1 share · 38,232 followers View post →
Nephrology Journal Club
@NephJC · X

Evidence on efficacy

May 21, 2024 · 4 likes · 38,232 followers View post →
cardio-met
@cardiomet_CE · X

32) #FIDELIODKD & #FIGARODKD included subgroup analyses in younger v older individuals, hidden in supplements or follow up pubs

Jun 7, 2023 · 4,157 followers View post →
Juan Carlos Obaya
@jcobaya69 · X

RT @cardiomet_CE: 12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained ↓ #eGFR > 40% or kidney death) ▶️ ↓ ~14% in…

Jun 6, 2023 · 2 shares · 857 followers View post →
Juan Carlos Obaya
@jcobaya69 · X

RT @cardiomet_CE: 15) #FIGARODKD was also a practice changing trial:

Jun 6, 2023 · 2 shares · 857 followers View post →
Ahmed Mohsen
@drahmedmohsen85 · X

RT @cardiomet_CE: 15) #FIGARODKD was also a practice changing trial:

Jun 6, 2023 · 2 shares · 22,804 followers View post →
Ahmed Mohsen
@drahmedmohsen85 · X

RT @cardiomet_CE: 12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained ↓ #eGFR > 40% or kidney death) ▶️ ↓ ~14% in…

Jun 6, 2023 · 2 shares · 22,804 followers View post →
Ahmed Mohsen
@drahmedmohsen85 · X

RT @cardiomet_CE: 11) #FIGARODKD & #FIDELIODKD studied #finerenone in pts with #T2D & #CKD at ↑risk (↑#UACR) for #cardiovascular & #kidney…

Jun 6, 2023 · 1 share · 22,804 followers View post →
cardio-met
@cardiomet_CE · X

15) #FIGARODKD was also a practice changing trial:

Jun 6, 2023 · 2 likes · 2 shares · 4,157 followers View post →
cardio-met
@cardiomet_CE · X

12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained ↓ #eGFR > 40% or kidney death) ▶️ ↓ ~14% in composite CV outcome This is a practice changing RCT : in pts with #T2D & #CKD with ↑ #UACR finerenone, ↓ heart & kidney risk

Jun 6, 2023 · 3 likes · 2 shares · 4,157 followers View post →
cardio-met
@cardiomet_CE · X

11) #FIGARODKD & #FIDELIODKD studied #finerenone in pts with #T2D & #CKD at ↑risk (↑#UACR) for #cardiovascular & #kidney complications despite maximal ACEi/ARB, with no compelling indications for steroidal #MRA (e.g., #CHF)

Jun 6, 2023 · 4 likes · 1 share · 4,157 followers View post →
Ahmed Mohsen
@drahmedmohsen85 · X

RT @cardiomet_CE: 35) In the #SGLT2i and #MRAtrials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:

May 31, 2023 · 3 shares · 22,804 followers View post →
JorgeEdoChava75
@QicenoJorge · X

RT @cardiomet_CE: 35) In the #SGLT2i and #MRAtrials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:

May 31, 2023 · 3 shares · 994 followers View post →
cardio-met
@cardiomet_CE · X

35) In the #SGLT2i and #MRAtrials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:

May 31, 2023 · 4 likes · 3 shares · 4,157 followers View post →
@CKD_ce
@ckd_ce · X

32) #FIDELIODKD & #FIGARODKD included subgroup analyses in younger v older individuals, hidden in supplements or follow up pubs

May 25, 2023 · 1 like · 2,637 followers View post →
DidemTurgut
@didemturgut_ · X

RT @ckd_ce: 15) #FIGARODKD was also a practice changing trial:

May 24, 2023 · 1 share · 911 followers View post →
DidemTurgut
@didemturgut_ · X

RT @ckd_ce: 12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained drop in #eGFR > 40% or kidney death) ▶️ ↓ ~14% in…

May 24, 2023 · 1 share · 911 followers View post →
DidemTurgut
@didemturgut_ · X

RT @ckd_ce: 11) #FIGARODKD & #FIDELIODKD studied #finerenone in pts with #T2D & #CKD at ↑risk (↑#UACR) for #cardiovascular & #kidney compli…

May 24, 2023 · 1 share · 911 followers View post →
@CKD_ce
@ckd_ce · X

15) #FIGARODKD was also a practice changing trial:

May 24, 2023 · 2 likes · 1 share · 2,637 followers View post →
@CKD_ce
@ckd_ce · X

12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained drop in #eGFR > 40% or kidney death) ▶️ ↓ ~14% in composite CV outcome This is a practice changing RCT: in pts w/#T2D & #CKD w/ ↑ #UACR finerenone, ↓ heart & kidney risk

May 24, 2023 · 2 likes · 1 share · 2,637 followers View post →
@CKD_ce
@ckd_ce · X

11) #FIGARODKD & #FIDELIODKD studied #finerenone in pts with #T2D & #CKD at ↑risk (↑#UACR) for #cardiovascular & #kidney complications despite maximal ACEi/ARB, with no compelling indications for steroidal #MRA(e.g., #CHF)

May 24, 2023 · 2 likes · 1 share · 2,637 followers View post →
Viet Le DMSc PA-C FACC FAHA HF-Cert
@VietHeartPA · X

@brianrosePAS We will miss you! Will be tonight my friend. Important to educate on nsMRA benefits to reduce CKD progression and reduce ASCVD events (driven by HF hosp and… cv death!). https://t.co/bAsbsQs6rw #AAPA23 @APAC_Cardiology https://t.co/y00qzR0oZ3

May 21, 2023 · 9,789 followers View post →
@CKD_ce
@ckd_ce · X

35) In the #SGLT2i and #MRA trials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:

May 18, 2023 · 1 like · 2,637 followers View post →
Héctor Rodrigo Rodríguez
@HRodrigoRV · X

FIGARO Trial 13% menos eventos de cardiovasculares: 29% menos hospitalizaciones por ICC

Apr 16, 2023 · 12 followers View post →
Daniel Schwartz, MD
@drdschwartzmd · X

Finerenone was studied in FIDELIO and FIGARO & enrolled when SGLT2i were not yet standard care https://t.co/VA1VwHO0AO https://t.co/WsR99nPP06

Nov 29, 2022 · 2 likes · 1,084 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

@drrayms @gbakris It is hypothesized that finerenone might potentially help mediate an effect on pneumonia & #COVID19: improvements in pulmonary inflammation & fibrosis, upregulation of expression of ACE2, amelioration of R heart pressure & pulm. congestion #Nephpearls

Oct 26, 2022 · 33,509 followers View post →
The Rounds Table
@roundstable · X

Pitt et al examined whether finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, would improve cardiovascular outcomes in patients with kidney disease and type 2 diabetes. Read more here https://t.co/AyjDfwmeFK

Sep 7, 2022 · 1 like · 2,235 followers View post →
Naheed
@nsali2 · X

@EzequielZaidel @thaiscoutinhoCV Yes it is. Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist sounds better. https://t.co/QdfWC2BRR8

Jul 1, 2022 · 29 followers View post →
ぽん@
@pharma_pon · X

腎臓病および2型糖尿病におけるフィネレノンによる心血管イベント Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/5kLrNxMfEK

Jun 17, 2022 · 1 like · 967 followers View post →
Erik Abel
@erik_e_abel · X

Think I missed these at the end 2021, all the more reason that early disease detection is key, particularly with interventions like SGLT2i in DM2 or these in DM2 with cardiorenal disease with Finerenone FIGARO: https://t.co/9bcMbi43EK FIDELIO: https://t.co/MdAX55SnSZ.

May 4, 2022 · 1,010 followers View post →
さくなお＠腎×小児薬剤師
@sakunao_study · X

新しいMR治療薬「フィネレノン」という薬が2型糖尿病を合併するCKDの心血管イベント発現や腎臓病進展を抑制する働きがあるとは！ Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/aw1bhBUHEC

Mar 28, 2022 · 226 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @FGarridoB: Según el FIGARO-DKD, Finerenona no solo retrasa la progresión de la enfermedad renal, sino que también previene los eventos…

Mar 23, 2022 · 4 shares · 2,143 followers View post →
د. سلطان خالد
@sul111ksa · X

@SultanS_Alotaib @B_ALDAAJANI Two RCTs: FIDELIO-DKD and FIGARO-DKD trails الاولى شاركها اخوي سلطان والثانية https://t.co/x45QdGC1VE

Mar 15, 2022 · 2 likes · 15,301 followers View post →
The Cardiometabolic Forum
@theCMforum · X

Pitt et al. suggests desirable effects on cardiorenal outcomes in patients with stage 3 or 4 CKD, T2D and severely elevated albuminuria. View our summary slides on the publication here: https://t.co/5yopwRbubx

Mar 6, 2022 · 257 followers View post →
The Cardiometabolic Forum
@theCMforum · X

A double-blind, placebo-controlled, event-driven Phase 3 trial by Pitt et al. randomised 7,437 patients to RAS blockade plus either finerenone or placebo, to investigate cardiorenal outcomes. View our summary slides now: https://t.co/5yopwRbubx

Mar 5, 2022 · 257 followers View post →
Letaief
@hmidato · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 28, 2022 · 18 shares · 369 followers View post →
Dr Bishal Agarwalla
@bishalagarwalla · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 27, 2022 · 18 shares · 198 followers View post →
Ana Maria Matias
@AMCMA6 · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 27, 2022 · 18 shares · 313 followers View post →
Santiago Moreno T.
@santy431 · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 27, 2022 · 18 shares · 604 followers View post →
Princesarann
@Princesarann1 · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 27, 2022 · 18 shares · 1 followers View post →
Basu Gopal
@BasuNephro · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 27, 2022 · 18 shares · 2,982 followers View post →
DidemTurgut
@didemturgut_ · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 27, 2022 · 18 shares · 911 followers View post →
Benito Valdepenas
@Benitocept · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 18 shares · 549 followers View post →
Gustavo Guevara Nolivos.
@gpguevara_nefro · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 18 shares · 363 followers View post →
ISN Education
@ISNeducation · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 4 shares · 10,484 followers View post →
Dr Theepa N.M.R
@TNesam · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 18 shares · 697 followers View post →
Paul mobey
@mpobey · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 4 shares · 95 followers View post →
Jen Li
@DrJenLi_Renal · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 18 shares · 714 followers View post →
Jen Li
@JLi_Renal · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 18 shares · 720 followers View post →
World Congress of Nephrology
@ISNWCN · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 4 shares · 5,814 followers View post →
ReVolBER
@RevolberMex · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 18 shares · 349 followers View post →
Anace Pastor ✨️ Renalis
@anace710 · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 18 shares · 1,901 followers View post →
Anace Pastor ✨️ Renalis
@anace710 · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 4 shares · 1,901 followers View post →
Hermann Hernández MD.
@HERMANNHV · X

RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…

Feb 26, 2022 · 18 shares · 210 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co/T6Tq2388a1 FIGARO-DKD https://t.co/r1V46C0aSU FIDELITY https://t.co/PgJJR8kI8B #VisualAbstract by @whatsthegfr #ISNWCN

Feb 26, 2022 · 32 likes · 18 shares · 33,509 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co/T6Tq2388a1 FIGARO-DKD https://t.co/r1V46C0aSU FIDELITY https://t.co/PgJJR8kI8B #VisualAbstract by @whatsthegfr #ISNWCN

Feb 26, 2022 · 8 likes · 4 shares · 33,509 followers View post →
DiabetoPitie
@DiabetoPitie · X

2/3 https://t.co/wHDIWH42ub

Feb 22, 2022 · 1 like · 290 followers View post →
Hugo Diniz, MD
@HDiniz_ · X

RT @SPNefro: Publication alert!

Feb 16, 2022 · 1 share · 1,333 followers View post →
Sociedade Portuguesa de Nefrologia
@SPNefro · X

Publication alert!

Feb 16, 2022 · 3 likes · 1 share · 561 followers View post →
Eduardo Hernández
@EduardoHn46 · X

#FIGARO-DKD *7352 pacientes con ERC 2-4 con alb/Cr urinaria 30-300 o ERC 1-2 con alb/Cr urinaria 300-5000 + DT2 *Muerte CV o IAM en 458 (12,4%) con #Finerenona vs 519 (14,2%) con placebo (HR 0,87; P=0,03) *Hospitalización por falla cardiaca (HR 0,71) DOI: 10.1056/NEJMoa2110956 https://t.co/MvOAIRxTu8

Feb 3, 2022 · 84 followers View post →
cardio-met
@cardiomet_CE · X

RT @ckd_ce: 22) FIGARO-DKD explored impact of finerenone in pts with #T2D & a wider range of #CKD. Unlike FIDELIO-DKD, FIGARO-DKD (https://…

Jan 20, 2022 · 3 shares · 4,157 followers View post →
AcademicCME
@academiccme · X

RT @ckd_ce: 22) FIGARO-DKD explored impact of finerenone in pts with #T2D & a wider range of #CKD. Unlike FIDELIO-DKD, FIGARO-DKD (https://…

Jan 20, 2022 · 3 shares · 648 followers View post →
soda_troubles,https://med-mastodon.com/@haysam
@set_fortess · X

RT @ckd_ce: 22) FIGARO-DKD explored impact of finerenone in pts with #T2D & a wider range of #CKD. Unlike FIDELIO-DKD, FIGARO-DKD (https://…

Jan 20, 2022 · 3 shares · 2,543 followers View post →
@CKD_ce
@ckd_ce · X

22) FIGARO-DKD explored impact of finerenone in pts with #T2D & a wider range of #CKD. Unlike FIDELIO-DKD, FIGARO-DKD (https://t.co/kSVp01OkN1) had a primary CV endpoint & a secondary renal endpoint but less advanced CKD. Nearly half had #microalbuminuria; mean eGFR was 68ml/min

Jan 20, 2022 · 5 likes · 3 shares · 2,637 followers View post →
Gunnar Henrik Heine
@gunnar_heine · X

@dgfn_ev https://t.co/AOldrTpX0D

Dec 28, 2021 · 2,330 followers View post →
Taiga
@tigktym · X

RT @CircSM: DM合併CKDへのfinerenone、有意にイベント抑制 MRAてほんとすごいですね そしてPitt先生の一貫性もすごい #NEJM https://t.co/G6l6ohBkwN

Dec 23, 2021 · 3 shares · 35 followers View post →
ときヲ
@toki_wo_koe · X

RT @uni_pharmacist: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/uXvvsGAEn2

Dec 22, 2021 · 1 share · 2,584 followers View post →
unimusashi（N. Ashikawa）
@uni_pharmacist · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/uXvvsGAEn2

Dec 22, 2021 · 3 likes · 1 share · 1,332 followers View post →
macky
@mackyTigers · X

国産MRBエサキセレノンは一体何やってんだ。のんびりしてるとあっちゅう間に追い抜かれるぞ Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ajVyuMnrtv

Dec 22, 2021 · 102 followers View post →
Drぷー
@Dr_ppooohh · X

RT @CircSM: DM合併CKDへのfinerenone、有意にイベント抑制 MRAてほんとすごいですね そしてPitt先生の一貫性もすごい #NEJM https://t.co/G6l6ohBkwN

Dec 22, 2021 · 3 shares · 24,748 followers View post →
Hiroyuki Sato 佐藤宏行
@foreverhero0819 · X

RT @CircSM: DM合併CKDへのfinerenone、有意にイベント抑制 MRAてほんとすごいですね そしてPitt先生の一貫性もすごい #NEJM https://t.co/G6l6ohBkwN

Dec 22, 2021 · 3 shares · 3,782 followers View post →
ShingoMatsumoto
@CardioSM · X

DM合併CKDへのfinerenone、有意にイベント抑制 MRAてほんとすごいですね そしてPitt先生の一貫性もすごい #NEJM https://t.co/G6l6ohBkwN

Dec 22, 2021 · 17 likes · 3 shares · 1,980 followers View post →
Billy Osler III
@SmrtMedNews · X

@NEJM 1/79 treated patients, (only 15% on GDMT, only 70% on statin) may delay a CHF hospitalization, without MI/CVA/GFR/ESRD benefit, is this really "clinically relevant? " @NephJC @ASNKidney #chf #hf #medtwitter #MedEd #NephJC #NephTwitter #nephrology https://t.co/rVyZYQNQH2

Dec 22, 2021 · 3 followers View post →
Jesus Casado
@JesusCasado20 · X

RT @IcyfaSemi: Finerenona en DM con FG entre 25-90 ml/min y albuminuria : ⬇️el MACE ampliado con

Dec 18, 2021 · 12 shares · 298 followers View post →
Giuseppe Biondi-Zoccai
@gbiondizoccai · X

RT @cpgale3: In this RCT of 7437 participants with type 2 #diabetes & stage 2 to 4 #CKD with moderately elevated albuminuria or stage 1 or…

Dec 17, 2021 · 1 share · 12,112 followers View post →
Prof Chris P Gale
@cpgale3 · X

In this RCT of 7437 participants with type 2 #diabetes & stage 2 to 4 #CKD with moderately elevated albuminuria or stage 1 or 2 CKD with severely elevated albuminuria, #finerenone therapy improved #cardiovascular outcomes as compared with placebo. https://t.co/eYFzEvTxGt

Dec 17, 2021 · 4 likes · 1 share · 13,470 followers View post →
Lorenzo Bertomeu
@LorenzoBertome1 · X

RT @ValleAlfonso:

Dec 15, 2021 · 12 shares · 340 followers View post →
VICTOR SANNA
@VICTORSANNA · X

RT @ASPNeph: Cardiovascular Events with #Finerenone in Kidney Disease and Type 2 #Diabetes. #CKD @NEJM https://t.co/UlIlN5d3YD

Dec 14, 2021 · 1 share · 2,591 followers View post →
American Society of Pediatric Nephrology
@ASPNeph · X

Cardiovascular Events with #Finerenone in Kidney Disease and Type 2 #Diabetes. #CKD @NEJM https://t.co/UlIlN5d3YD

Dec 14, 2021 · 2 likes · 1 share · 10,122 followers View post →
Jose Carlos Arevalo
@joscarlor2 · X

RT @ManoloBeltranR: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ucqr5dGdGe

Dec 12, 2021 · 1 share · 757 followers View post →
Manuel Beltrán
@ManoloBeltranR · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ucqr5dGdGe

Dec 12, 2021 · 4 likes · 1 share · 579 followers View post →
Luis Caminal
@caminalm · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/uWKpSlkOQT

Dec 12, 2021 · 965 followers View post →
Fernando Civeira
@FernandoCiveir1 · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/690tXvFuYR

Dec 9, 2021 · 1 like · 343 followers View post →
Dr Jean Pierre Laroche #vacciné 6.0
@Echoraljpangio · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/iNv5i5OFLT

Dec 8, 2021 · 1 like · 2,714 followers View post →
Repositorio ABACUS
@AbacusUE · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/B5lgwBeL3H

Nov 27, 2021 · 267 followers View post →
青島周一
@syuichiao89 · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/xTiyuIXJdn

Oct 4, 2021 · 1 like · 8,610 followers View post →
CardiologyTalk
@CardiologyTalk · X

Podcast- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes, Bertram Pitt, M.D. - @UMich @UMichCardiology #CardiovascularEvents #Cardiology #research Link to Audio- https://t.co/4y52ccfC8i https://t.co/E0YTGDbVJK

Sep 23, 2021 · 722 followers View post →
CardiologyTalk
@CardiologyTalk · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes, Bertram Pitt, M.D. - @UMich @UMichCardiology #CardiovascularEvents #Cardiology #Research https://t.co/33hprMHWhd https://t.co/FXTKxN3Q3g

Sep 23, 2021 · 722 followers View post →
Beatriz Fernandez Fernandez
@beaff26 · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…

Sep 11, 2021 · 9 shares · 2,305 followers View post →
Aaron Liew MB BCh, MPH, PhD
@AARONLYL · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/QFIVlghXav

Sep 7, 2021 · 2 likes · 98 followers View post →
Mohamed Hamedh MSc, MD
@mohamedhamedh2 · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/KR4dNyaClx

Sep 7, 2021 · 1 like · 616 followers View post →
Cardio Renal Metabolic Connections
@cardio_renal · X

RT @SBansalNeph: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/fdfOYPjoVb

Aug 31, 2021 · 3 shares · 425 followers View post →
Cat Shah
@NPlubdub · X

RT @SBansalNeph: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/fdfOYPjoVb

Aug 31, 2021 · 3 shares · 271 followers View post →
Rodolfo J. Galindo MD
@RodolfoJGalindo · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…

Aug 29, 2021 · 5 shares · 1,100 followers View post →
Javier Escalada #Yoelijoendocrino
@fjavesc · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…

Aug 29, 2021 · 5 shares · 3,618 followers View post →
Ingrid Billaut
@IBillaut · X

RT @SeguraCardio:

Aug 29, 2021 · 19 shares · 26 followers View post →
Linda
@wordfinga · X

RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…

Aug 29, 2021 · 9 shares · 4,597 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 29, 2021 · 16 shares · 2,143 followers View post →
Eduard Centeno
@segol60 · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 29, 2021 · 11 shares · 409 followers View post →
IGOARANBA
@IGOARANBAR · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…

Aug 29, 2021 · 9 shares · 1,760 followers View post →
Pablo Perez Martinez
@PabloPerezMar16 · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/d3U30LuSHa

Aug 29, 2021 · 2 likes · 1,304 followers View post →
fausto heredia z.
@drfherediaz · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 29, 2021 · 16 shares · 4,354 followers View post →
Giuseppe Maltese
@docmaltese · X

RT @SurendranAarthi: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ZbcbIs9jI2. CVO impro…

Aug 29, 2021 · 1 share · 1,769 followers View post →
Paula Madalina Lupu
@PaulaMadalinaL1 · X

RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…

Aug 29, 2021 · 9 shares · 13 followers View post →
Linda
@wordfinga · X

RT @mzkhalil: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. | NEJM #ESCCongress https://t.co/HgOH6veEnT

Aug 29, 2021 · 1 share · 4,597 followers View post →
Felice Gragnano
@FeliceGragnano · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 29, 2021 · 16 shares · 5,268 followers View post →
Héctor Meckler
@mecklerh · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 29, 2021 · 11 shares · 316 followers View post →
Edgard Manrique Alva
@Manriqardio · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 28, 2021 · 11 shares · 134 followers View post →
Ivan Mendoza
@mencardio · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 28, 2021 · 11 shares · 7,260 followers View post →
Carlos Maiorana
@MaioranaCarlos · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 28, 2021 · 11 shares · 344 followers View post →
todayheadline
@TodayHeadline42 · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes – https://t.co/ZYBwqO9hdm https://t.co/HQcNn9KlUd

Aug 28, 2021 · 683 followers View post →
Linda Lopez-George, Ed.D.
@LindaLopezGeo1 · X

RT @SBansalNeph: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/fdfOYPjoVb

Aug 28, 2021 · 3 shares · 228 followers View post →
Oscar Andres
@OscarAndresMD · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…

Aug 28, 2021 · 5 shares · 556 followers View post →
Euro Journal - English News
@eurojournalENG · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/LoHW2aQdsh

Aug 28, 2021 · 1,740 followers View post →
the paper link
@the_paper_link · X

Trend new: Pitt B, ..., Figaro-dkd Investigators (N Engl J Med) __Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes__ https://t.co/MGSVd5IQyR

Aug 28, 2021 · 136 followers View post →
Professor M Z Khalil
@mzkhalil · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. | NEJM #ESCCongress https://t.co/HgOH6veEnT

Aug 28, 2021 · 1 like · 1 share · 2,855 followers View post →
名前
@akkiii0830 · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/PRoQjOxyeQ

Aug 28, 2021 · 245 followers View post →
Aarthi Surendran
@SurendranAarthi · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ZbcbIs9jI2. CVO improves with finerenone in patients with CKD 2-4. Bear in mind hyperkalaemia. @DrMohamedBakhit @docmaltese @drdanidixon @drpatrickholmes @drkevinfernando

Aug 28, 2021 · 6 likes · 1 share · 495 followers View post →
Shweta Bansal
@SBansalNeph · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/fdfOYPjoVb

Aug 28, 2021 · 5 likes · 3 shares · 635 followers View post →
José Luis Añorga Ocmin, MD
@Joseluis_MD29 · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 347 followers View post →
Dr. Jose Gabian Fortes
@gabianfortes · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 250 followers View post →
Dr Jean Pierre Laroche #vacciné 6.0
@Echoraljpangio · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/mA51ksVAOy https://t.co/NC92ojTScC

Aug 28, 2021 · 2,714 followers View post →
Dr. Shashank Joshi
@AskDrShashank · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 32,522 followers View post →
CNCFCardio
@CNCFCardio · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 5,284 followers View post →
Peter Rossing
@P_Rossing · X

RT @FrederikPersson: Remember to measure UACR in #T2D and start best treatment. Now from @P_Rossing from @Stenodiabetes and global investi…

Aug 28, 2021 · 1 share · 1,538 followers View post →
Angela Romero Zarante, MD
@ANGELARZ28 · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 308 followers View post →
Angela Romero Zarante, MD
@ANGELARZ28 · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 28, 2021 · 11 shares · 308 followers View post →
juan lopez
@jd1lopez · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 28, 2021 · 11 shares · 1,075 followers View post →
Diego Bellido
@DiegoBellido2 · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…

Aug 28, 2021 · 9 shares · 8,212 followers View post →
Julio
@yulnunezvill · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 28, 2021 · 11 shares · 4,252 followers View post →
Dr.Rajiv Sankaranarayanan
@DrRajivsankar · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 3,983 followers View post →
Flora López Simarro
@flopezsim · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…

Aug 28, 2021 · 9 shares · 703 followers View post →
Rosa Fernandez
@MAROSFO · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 3,309 followers View post →
Oscar Moreno #
@moreno_perez_o · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…

Aug 28, 2021 · 9 shares · 3,397 followers View post →
Ekaterini Lambrinou
@EkateriniL · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 3,388 followers View post →
Vicente Arrarte
@varrarte · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…

Aug 28, 2021 · 5 shares · 3,579 followers View post →
Vicente Arrarte
@varrarte · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 28, 2021 · 11 shares · 3,579 followers View post →
Dani Salas
@pollitodeanaga · X

RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…

Aug 28, 2021 · 11 shares · 413 followers View post →
Dani Salas
@pollitodeanaga · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 413 followers View post →
Fco Carramiñana Barrera
@fcbzafra · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…

Aug 28, 2021 · 9 shares · 2,749 followers View post →
GT Diabetes Semergen
@SemergenGTDM · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…

Aug 28, 2021 · 9 shares · 3,338 followers View post →
redGDPS Diabetes
@redGDPS · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…

Aug 28, 2021 · 9 shares · 15,486 followers View post →
José R. Juanatey
@JoseJuanatey · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejorar el pronóstico de diabéticos con enfermedad renal crónica! ⁦@secardiologia⁩ #ESCcongress https://t.co/mJK0PygMiF

Aug 28, 2021 · 21 likes · 11 shares · 13,758 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 2,143 followers View post →
Javier Torres
@JTLLERGO · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 5,159 followers View post →
Anja
@piepsi_228 · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 25 followers View post →
fausto heredia z.
@drfherediaz · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…

Aug 28, 2021 · 5 shares · 4,354 followers View post →
Laura Alvarez
@pipertaza · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 611 followers View post →
champ_wayne
@champ_wayne · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 1,654 followers View post →
C. Delgado ☯️
@cris_pitita · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/KmUXG7R3kK

Aug 28, 2021 · 125 followers View post →
Ryan Chizner, DO, MPH, RPVI, FACC
@ChiznerRyan · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 344 followers View post →
Khalill Peeroo
@Khalill_ · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 157 followers View post →
Guillaume Bonnet
@guilbon · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 3,483 followers View post →
Jose Luis Górriz
@jlgorriz · X

RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…

Aug 28, 2021 · 9 shares · 8,588 followers View post →
Adrián RH
@_telurio · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 54 followers View post →
Maja Cikes
@MajaCikes · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 895 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

Cardiovascular Events with #Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/dFRCqtt7I4

Aug 28, 2021 · 2,143 followers View post →
Cristobal Morales
@CristobMorales · X

https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SEDiabetes @SENefrologia @secardiologia @redGDPS @SEMERGENap @ValleAlfonso @fjavesc @jlgorriz @almucastro01 @DrTinahones @DiegoBellido2 @moreno_perez_o https://t.co/H5ETEhI6dT

Aug 28, 2021 · 18 likes · 9 shares · 17,026 followers View post →
CardioEd Bot
@CardioBot · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 1,202 followers View post →
Charles Pollack MD
@md_pollack · X

RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…

Aug 28, 2021 · 9 shares · 281 followers View post →
Kevin Fernando
@drkevinfernando · X

RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…

Aug 28, 2021 · 9 shares · 5,133 followers View post →
cardio-met
@cardiomet_CE · X

RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…

Aug 28, 2021 · 9 shares · 4,157 followers View post →
Cristobal Morales
@CristobMorales · X

https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patients with t2DM and stage 2 to 4 CKD with moderately albuminuria or stage 1 or 2 CKD with severely albuminuria, finerenone therapy improved cardiovascular outcomes

Aug 28, 2021 · 10 likes · 5 shares · 17,026 followers View post →
Kenar Jhaveri
@kdjhaveri · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | ⁦@NEJM⁩ https://t.co/LJRotsuX7d

Aug 28, 2021 · 11 likes · 11,651 followers View post →
Dimitris Papamargaritis
@ri_tis · X

RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…

Aug 28, 2021 · 9 shares · 699 followers View post →
Dr. Michael Alexander
@MichaelAlexandp · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/IXnTNOZ1Fj

Aug 28, 2021 · 840 followers View post →
Harriette Van Spall, MD MPH
@hvanspall · X

RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…

Aug 28, 2021 · 9 shares · 17,799 followers View post →
Dr Umesh Prabhu
@DrUmeshPrabhu · X

RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…

Aug 28, 2021 · 9 shares · 30,019 followers View post →
Dr. Martha Gulati ♥️
@DrMarthaGulati · X

RT @SeguraCardio:

Aug 28, 2021 · 19 shares · 64,641 followers View post →
GoggleDocs
@GoggleDocs · X

RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…

Aug 28, 2021 · 9 shares · 3,646 followers View post →
Alessia Gimelli
@alessia_gimelli · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 3,589 followers View post →
Diego Segura-Rodríguez
@SeguraCardio · X

Aug 28, 2021 · 63 likes · 19 shares · 25,725 followers View post →
Dr Amar Puttanna
@AmarPut · X

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @drpatrickholmes @drkevinfernando @kamleshkhunti @cardiomet_CE @GoggleDocs @brendonneuen @VladoPerkovic @SABOURETCardio @hvanspall @ErinMichos @docwas

Aug 28, 2021 · 20 likes · 9 shares · 3,623 followers View post →
Muneeb Jan
@manutd91 · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 2,088 followers View post →
European Society of Cardiology
@escardio · X

RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…

Aug 28, 2021 · 16 shares · 149,512 followers View post →